Gujarat Kidney And Super Speciality (GKSL) — Board Meeting

1 Board Meeting 🟡 Notable Neutral 📄 PDF

📢 Key Event
Board approved unaudited Q1 financial results

💡 Investor Takeaway
The approved results show no material misstatements, but lack forward-looking guidance for investor confidence.

The Board reviewed and approved the unaudited standalone and consolidated financial results for Q1 ending June 30, 2026, confirming compliance with SEBI Regulation 33 and applicable accounting standards. The independent auditor issued a limited review report with no material misstatements identified, providing moderate assurance on disclosure completeness. No operational changes or forward-looking statements were disclosed in the filing.

2 Board Meeting 🟡 Notable Neutral 📄 PDF

📢 Key Event
Appointment of Mr. Paresh Dhoti as Additional Non-Executive Independent Director

🔄 What Changed
Category changed from Non-Executive Non-Independent Director to Non-Executive Independent Director

🔮 What's Next
Subject to shareholder approval at the ensuing Annual General Meeting

💡 Investor Takeaway
This strengthens board independence without dilution or immediate financial impact.

Gujarat Kidney And Superspeciality Limited announced the appointment of Mr. Paresh Dhoti as an Additional Non-Executive Independent Director effective 14.08.2026, following Board approval on 09.07.2026 and subject to shareholder ratification at the upcoming AGM, with his term set for five consecutive years and no retirement by rotation.

📊 Stock Analysis — GKSL ✨ Ask AI About This

About Gujarat Kidney And Super Speciality Limited (GKSL)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹1,250.85 Cr P/E: 64.5 ROE: 64.5% ROCE: 77.4%

View full GKSL stock details →

📡 Get AI alerts when GKSL files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GKSL — Free

💡 Ask AI about this filing

"What is the year-on-year revenue growth?" "How does Q1 profit margin compare to previous quarters?" "What is the company's dividend policy outlook?"

Ask AI Free →

📊 More GKSL filings

See all GKSL filings →

🔥 Also filed on 14 August 2026

CEIGALL Ceigall India Limited Financial Results MAHAPEXLTD Maha Rashtra Apex Corporation Limited Corporate Action SAATVIKGL Saatvik Green Energy Limited Financial Results LIBAS Libas Consumer Products Limited Corporate Action GENUSPOWER Genus Power Infrastructures Limited Financial Results LUXIND Lux Industries Limited Financial Results

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GKSL files new disclosures

Track GKSL filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GKSL — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd

Gujarat Kidney And Super Speciality Limited (GKSL) — Board Meeting | 14 August 2026(2 announcements)

About Gujarat Kidney And Super Speciality Limited (GKSL)

📡 Get AI alerts when GKSL files next

💡 Ask AI about this filing

📊 More GKSL filings

🔥 Also filed on 14 August 2026